Hisashi Ohta

Title: Hisashi Ohta: Innovator in Pharmaceutical Chemistry

Introduction

Hisashi Ohta is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various brain disorders and mental dysfunctions. With a total of 6 patents to his name, Ohta's work has the potential to impact the treatment of several medical conditions.

Latest Patents

One of Hisashi Ohta's latest patents involves 1,4-substituted piperazine derivatives. This compound is represented by the formula (I) or a pharmaceutically acceptable salt thereof. It exhibits a metabotropic glutamate receptor 1 inhibitory effect, making it useful for treating brain disorders such as convulsions, acute pain, inflammatory pain, chronic pain, cerebral infarction, or transient cerebral ischemic attacks. Additionally, it addresses mental dysfunctions like schizophrenia and diseases such as anxiety and drug addiction. Another notable patent is for diaryl-substituted five-membered heterocycle derivatives, which are also represented by formula (I) or pharmaceutical salts thereof.

Career Highlights

Throughout his career, Hisashi Ohta has worked with reputable companies, including Banyu Pharmaceutical Co. Ltd and MSD K.K. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Hisashi Ohta has collaborated with notable colleagues, including Hiroshi Kawamoto and Atsushi Satoh. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Hisashi Ohta's contributions to pharmaceutical chemistry highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in the treatment of various brain disorders and mental health issues.